Takeda Pharmaceutical Company Limited
4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINE MODULATORS OF GPR139
Last updated:
Abstract:
The present invention provides a method for treating a disease, disorder or condition associated with GPR139 using compounds of formula 1: ##STR00001## which are agonists of GPR139, certain compounds encompassed by formula 1, pharmaceutical compositions thereof, processes for making the compounds, and intermediates thereof.
Status:
Application
Type:
Utility
Filling date:
2 Jan 2020
Issue date:
30 Apr 2020